close
close

Cathie Wood has a vision for biotech: new priorities at ARK Invest? | 08.09.24

• ARK Invest invests in sports data infrastructure
• Strong focus on Biotechnology

• Provide technology at Kaufzettel

My firm ARK Invest has sold several ETFs from Cathie Wood and specialized in innovative technology sector. You can be sure that a few things are happening. So how you used to see a Genius Sports, a company on the bereich sportdata, big amounts and a round of 3’625’498 US-Dollar-purchases.

Biotech in pictures

Your branded wooden hat is a product and a piece of furniture that you can use on biotech companies. I look at the results in the health technology sector that the investor in another with a big profit of Tempus AI-Aktien has seen. As one of the US dollar papers in the world of more billion dollar wars between the US and the dollar dies by the largest capital investments, which Investing.com concrete. Tempus AI is a technology in health care, which provides intelligent intelligence to learn machines in those reach conditions.

Look at Arcturus Therapeutics, a US biotech company for RNA meds, Cathie Wood invests 44,875 shares in the ARKG ETF worth around 986,801 US dollars. As Investing.com further noted, ARK Invest continues to maintain its position in the company. There are more biotech companies that have invested in Cathie Wood in War Guardant Health. So the star investor in the ARKG ETF 29,147 shares in a volume of 845,845 US dollars. Then Wood invested with the ARKK and the ARKG ETF with 105,818 Intellia Therapeutics shares in a value of 2,433,814 US dollars.

Few days see Wood ties with the American biotechnology group Recursion Pharmaceuticals to use the Swiss Group CRISPR Therapeutics.

Auch Technology Unternehmen fragmented

If you’re into biotech kits, wood is one way you can use technology like the e-commerce software Shopify or the online gaming platform Roblox.

Editorial staff finanzen.ch

This text is intended primarily to contain information and does not constitute an endorsement. Die finanzen.net GmbH schliesst jegliche Regressansprüche aus.